Medical manufacturing's prescription for successWhen medical-device manufacturers launch efforts to cut manufacturing costs associated with existing products, they must often do so without undergoing redesigns. The reason: by the time a medical product is outsourced, it has completed its Food & Drug Administration (FDA) approval cycle, making even simple design for manufacturability or testability (DFM/DFT) changes difficult. The incorporation of lean manufacturing principles as practiced by EPIC Technologies, a Norwalk, Ohio-based electronics manufacturing services provider, is proving to be an effective means for meeting this industry-specific manufacturing challenge. "We're applying Advanced Product Quality Planning (APQP) techniques developed by the automotive industry," says Ryan Wooten, engineering manager. "These include development of customer required processes through dedication of internal Customer Focus Teams (CFT); utilization of pre-build DFx analysis for manufacturability and testability; reliability laboratory analysis during new product process validation stages; and a focused product launch process with feedback, assessment and corrective action mechanisms to ensure that product meets customer requirements." Wooten says, "The first step in this process is the design review summary, listing the recommendations of the DFM evaluation with one to five points assigned to each according to level of urgency. For example, if a product has a serious design issue, it receives five points and will not be built, but this is rare. The lesser the design issue, the lesser the point score. For example, if there are issues that 'probably' should be corrected, but aren't really major, three points would be scored. And, in cases where it might be 'nice to have' certain design features that aren't 'critical,' one point would be scored. "This ranking system helps us to focus our DFM and DFT recommendations in a cost-benefit framework and prioritize discussions on the critical recommendations," Wooten continues. "The company's internal DFM and DFT guidelines are based on industry-accepted guidelines, which are based on those published by IPC (a global trade association for the electronics interconnect industry) and enhanced through production experience and validations. Customer design teams are provided with these guidelines early in the process to stimulate open communication." Out with the wasteEPIC's efforts to eliminate non-value added activities include the following:
Reliability testing is team effortEPIC'S reliability lab is co-managed by quality and engineering to ensure that there is agreement on support provided. A process engineer, trained in reliability lab processes, runs the lab. Data is collected in production per lab request; appropriate analysis is performed in the lab; reports are generated; appropriate stakeholder reviews are performed; and corrective actions are implemented. The lab focuses on three key areas: new process definition and validation, project launch and quality issue resolution.Defects often occur as the result of supplier or customer issues rather than in the contractor's process, making quality resolution especially important. Understanding defect risks driven by final assembly processes or end-market applications is critical. For example, as boards become more densely populated, ball grid arrays (BGAs) are in wide use. If the PCBA is flexed too much in the box-build assembly process, stress fractures may occur that ultimately drive hard-to-identify field failures. The faster these issues are identified and corrected, the lower the cost impact on the product launch. The reliability lab originally addressed these issues as defects occurred. As PCBA complexity increased, the group started offering a package of services to better validate process robustness at both the lab and at customers' operations as part of the new product introduction process.
|
||||||
|
|
||||||
|---|---|---|---|---|---|---|
|
|